Ron Pasewald joined us on #RTSidebar to discuss a big topic in the respiratory community, compact licensure. It is important not only for RTs but also for patients. Tune in wherever you get your podcasts to hear the full episode!
Vapotherm
Medical Equipment Manufacturing
Exeter, NH 24,412 followers
The only mask-free respiratory support tool- an alternative to NiPPV for treating undifferentiated respiratory distress.
About us
Vapotherm, Inc. is the inventor of high flow nasal cannula, and its advanced form: Vapotherm high velocity therapy. Delivering high velocity therapy, the Precision Flow® system offers clinicians a reliable tool for multiple patient populations. For respiratory distress patients presenting in the ED and ICU, high velocity therapy can provide not just oxygenation, but also Mask-Free respiratory support with the comfort of heated humidified high flow. Vapotherm, Inc. is a publicly traded company and its common stock trades on the OTCQX tier of the OTC Markets under the symbol “VAPO”.
- Website
-
http://www.vapotherm.com
External link for Vapotherm
- Industry
- Medical Equipment Manufacturing
- Company size
- 201-500 employees
- Headquarters
- Exeter, NH
- Type
- Public Company
- Founded
- 1999
- Specialties
- Respiratory Medical Device Development and Manufacturing and Marketing
Locations
-
Primary
100 Domain Drive
Exeter, NH 03833, US
Employees at Vapotherm
Updates
-
Described by these clinicians as a “game-changing” experience, discover #Vapotherm technology for providing respiratory therapy on the go! #HighVelocityTherapy
-
Up next on #RTSidebar - A legally bald episode We are talking to guest and ethics instructor Michael Sheahan Ed.D., RRT-NPS about the legal, ethical and moral side of respiratory therapy as he shares his experience as an expert witness. 🧐 Tune in on Friday, July 12th at 12 pm EST! #Barflies
-
-
Save your seat for our first ever night shift webinar! Tuesday, July 16th at 10:00 pm EST Join three of the Principal Investigators of HYPERACT, the 2024 Society of Critical Care Medicine Star Research Award Winner, which determined High Velocity Therapy as a reasonable alternative to NiPPV for moderate - severely hypercapnic, COPD patients (for spontaneously breathing patients only). See you there! #HYPERACT #Vapotherm #LiveWebinar #FreeCEU
The Late Night Webinar - HYPERACT
www.linkedin.com
-
We’re pleased to announce we’ve entered into agreements with a new investor, Perceptive, and our existing lender, SLR, to fund Vapotherm’s future growth! Congrats to all the team members who made this possible! For more information, https://lnkd.in/eJFdCvdQ
-
In recognition of #Juneteenth, Vapotherm's US offices will be closed. June 19 marks the day when federal troops arrived in Galveston, Texas in 1865 to take control of the state and ensure that all enslaved people were freed. This day honors the end of slavery in the United States and demonstrates the ongoing fight for racial equality.
-
Is it a bird? Is it a plane? No, it’s Monique Steffani! Take flight with us next week on RT Side bar and for the live recording on Thursday, June 26th 2:00-3:00pm EST / 11:00-12:00 pm PST Monique Steffani has been an RT for 22 years. Her career includes caring for neonates to adults, education, and pharmaceutical & medical device industry. She's on the transport team at CHOC Children's Hospital, a Clinical Specialist for Mallinkrdodt, and faculty at Concordia University. She's spent time on the CSRC board and AARC special committees and is committed to bringing awareness to the public about the respiratory care profession.
-
-
Does your hospital struggle finding a safe, effective, easy to use respiratory support option for stabilizing patients in respiratory distress? This quick read dives into 5 benefits of the HVT 2.0 device for small, sometimes rural, hospitals. What’s your favorite feature? #RideTheWAV #Vapotherm #RespiratoryCare
Five Benefits Vapotherm HVT 2.0 Can Offer Small (Sometimes Rural) Hospitals
Vapotherm on LinkedIn